Valganciclovir 50mg/mL Oral Suspension from Mexico
Liquid oral suspension at 50mg/mL valganciclovir hydrochloride for pediatric or swallowing-impaired patients treating CMV disease. HTS 3004.90.92.05 applies as it's a measured dose antiviral containing valganciclovir salt for retail therapeutic use.
Duty Rate — Mexico → United States
100%
Rate breakdown
9903.04.60100%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Provide validated stability data for liquid formulation under varying storage conditions
• Ensure child-resistant closures meet CPSC standards for liquid medicaments
• Test for microbial contamination specific to oral suspensions during import inspection